Early Initiation of Antiretroviral Therapy Can Functionally Control Productive HIV-1 Infection in Humanized-BLT Mice

Journal of Acquired Immune Deficiency Syndromes

Volumn 69, Issue 5, 2015, Pages 519-527

  Li, Qingsheng ^a   Tso, For Yue ^a   Kang, Guobin ^a   Lu, Wuxun ^a   Li, Yue ^a,c   Fan, Wenjin ^a   Yuan, Zhe ^a   Destache, Christopher J ^b   Wood, Charles ^a  

^a UNIVERSITY OF NEBRASKA   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF PHARMACY AND HEALTH PROFESSIONS   (United States)

^c NANKAI UNIVERSITY   (China)

Author keywords

early ART; functional control; HIV 1 infection; hu BLT mice

Indexed keywords

LAMIVUDINE; TENOFOVIR DISOPROXIL; VIRUS DNA; VIRUS RNA; ADENINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CD34 ANTIGEN; PHOSPHONIC ACID DERIVATIVE; TENOFOVIR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL THERAPY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMPARATIVE STUDY; CONTROLLED STUDY; FLOW CYTOMETRY; GENE DOSAGE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN SITU HYBRIDIZATION; INFECTION CONTROL; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T CELL DEPLETION; TREATMENT DURATION; VIRUS LOAD; ANALOGS AND DERIVATIVES; ANIMAL; BONE MARROW; DISEASE COURSE; DISEASE MODEL; DRUG EFFECTS; GENETICS; HIV INFECTIONS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER; METABOLISM; NONOBESE DIABETIC MOUSE; PHYSIOLOGY; PILOT STUDY; SPLEEN; THYMUS; TRANSGENIC MOUSE; VIROLOGY; VIRUS REPLICATION;

ADENINE; ANIMALS; ANTI-HIV AGENTS; ANTIGENS, CD34; BONE MARROW; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DNA, VIRAL; GENE DOSAGE; HIV INFECTIONS; HIV-1; HUMANS; LIVER; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; ORGANOPHOSPHONATES; PILOT PROJECTS; RNA, VIRAL; SPLEEN; TENOFOVIR; THYMUS GLAND; VIRAL LOAD; VIRUS REPLICATION;

EID: 84937802356     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000687     Document Type: Article

References (30)

1. Piot P, Quinn TC. Response to the AIDS pandemic-a global health model. N Engl J Med. 2013;368:2210-2218.
2. Phongsamart W, Hansudewechakul R, Bunupuradah T, et al. Long-term outcomes of HIV-infected children in Thailand: the Thailand pediatric HIV observational database. Int J Infect Dis. 2014;22:19-24.
3. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493-505.
4. UNAIDS. Global Report: UNAIDS Report on the Global AIDS Epidemic. The Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland; 2013.
5. Hutter G, Nowak D, Mossner M, et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med. 2009; 360:692-698.
6. Persaud D, Gay H, Ziemniak C, et al. Absence of detectable HIV-1 viremia after treatment cessation in an infant. N Engl J Med. 2013;369: 1828-1835.
7. "Mississippi Baby" Now Has Detectable HIV, Researchers Find. National Institute of Allergy and Infectious Diseases. NIH News. Available at: http://www.niaid.nih.gov/news/newsreleases/2014/pages/mississippibabyhiv.aspx. Accessed July 10, 2014.
8. Cillo AR, Krishnan A, Mitsuyasu RT, et al. Plasma viremia and cellular HIV-1 DNA persist despite autologous hematopoietic stem cell transplantation for HIV-related lymphoma. J Acquir Immune Defic Syndr. 2013;63:438-441.
9. Henrich TJ, Hu Z, Li JZ, et al. Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation. J Infect Dis. 2013;207:1694-1702.
10. Melkus MW, Estes JD, Padgett-Thomas A, et al. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med. 2006;12:1316-1322.
11. Sun Z, Denton PW, Estes JD, et al. Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1. J Exp Med. 2007;204:705-714.
12. Denton PW, Estes JD, Sun Z, et al. Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med. 2008;5:e16.
13. Wheeler LA, Trifonova R, Vrbanac V, et al. Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras. J Clin Invest. 2011;121:2401-2412.
14. Brainard DM, Seung E, Frahm N, et al. Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice. J Virol. 2009;83: 7305-7321.
15. Dudek TE, No DC, Seung E, et al. Rapid evolution of HIV-1 to functional CD8(+) T cell responses in humanized BLT mice. Sci Transl Med. 2012;4:143ra198.
16. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am JHyg. 1938;27:493-497.
17. Wang LX, Kang G, Kumar P, et al. Humanized-BLT mouse model of Kaposi's sarcoma-associated herpesvirus infection. Proc Natl Acad Sci USA. 2014;111:3146-3151.
18. Li Q, Duan L, Estes JD, et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature. 2005; 434:1148-1152.
19. Gianella S, von Wyl V, Fischer M, et al. Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA. Antivir Ther. 2011;16:535-545.
20. Wyl V, Gianella S, Fischer M, et al. Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption. PLoS One. 2011;6:e27463.
21. Jin X, Bauer DE, Tuttleton SE, et al. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med. 1999;189:991-998.
22. Schmitz JE, Kuroda MJ, Santra S, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science. 1999; 283:857-860.
23. Eriksson S, Graf EH, Dahl V, et al. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathog. 2013;9: e1003174.
24. Pinheiro LB, Coleman VA, Hindson CM, et al. Evaluation of a droplet digital polymerase chain reaction format for DNA copy number quantification. Anal Chem. 2011;84:1003-1011.
25. Pandrea I, Gaufin T, Gautam R, et al. Functional cure of SIVagm infection in rhesus macaques results in complete recovery of CD4+ T cells and is reverted by CD8+ cell depletion. PLoS Pathog. 2011;7:e1002170.
26. Saez-Cirion A, Bacchus C, Hocqueloux L, et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog. 2013;9:e1003211.
27. Vanham G, Buve A, Florence E, et al. What is the significance of posttreatment control of HIV infection vis-a-vis functional cure? AIDS. 2013;28:603-605.
28. Lifson JD, Rossio JL, Arnaout R, et al. Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment. J Virol. 2000;74:2584-2593.
29. Soriano-Sarabia N, Bateson RE, Dahl NP, et al. The quantitation of replication-competent HIV-1 in populations of resting CD4+ T cells. J Virol. 2014;88:14070-14077.
30. Koelsch KK, Liu L, Haubrich R, et al. Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro. J Infect Dis. 2008;197:411-419.